MYL6B, a myosin light chain, promotes MDM2-mediated p53 degradation and drives HCC development

BACKGROUND: Identification of novel MDM2 or p53 binding proteins may reveal undefined oncogenes, tumor suppressors, signaling pathways and possible treatment targets. METHODS: By means of immunoprecipitation and Mass Spectrometry analysis, we aimed to identify novel regulators of the MDM2-p53 pathwa...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xingwang, Wang, Xueyan, Liao, Weijia, Fei, Ran, Wu, Nan, Cong, Xu, Chen, Qian, Wei, Lai, Wang, Yu, Chen, Hongsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812214/
https://www.ncbi.nlm.nih.gov/pubmed/29439719
http://dx.doi.org/10.1186/s13046-018-0693-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812214/
https://www.ncbi.nlm.nih.gov/pubmed/29439719
http://dx.doi.org/10.1186/s13046-018-0693-7

Ejemplares similares